|
ASCO: Patient income affects trial enrollment
 June 4, 2012 -- The lower their income, the less likely patients are to participate in cancer clinical trials, according to a study presented at the American Society of Clinical Oncology (ASCO) annual meeting, currently under way in Chicago.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
Patients with incomes less than $20,000 were 44% less likely to enroll in clinical trials than patients with higher annual incomes. For patients with annual incomes of $20,000 to $50,000, the rate was 27%.
The cost of participating in a clinical trial was a key concern for 53% of patients with incomes less than $20,000, compared with 24% of patients whose income was more than $100,000 per year, according to presenter Dr. Kathy Albain, an oncologist and professor of hematology/oncology at Loyola University Medical Center.
She chaired the committee that developed and designed the study, which was a collaboration between the Southwest Oncology Group (SWOG) and patient education services and market research company NexCura.
Albain and co-researchers designed an online survey of 5,499 patients who were newly diagnosed with breast, prostate, lung, or colorectal cancers. Overall, 9% of these patients participated in clinical trials. Income was the only socioeconomic or demographic factor that was significantly associated with study participation. | |
|